Contributing to better clinical outcomes and accelerating time to market for structural heart interventions
FEops offers the first and only patient-specific simulation technology for structural heart interventions, surpassing basic anatomical measurement by accurately predicting how devices will interact with each unique patient. Our end-to-end solution adds value at every step in the structural heart product life cycle, helping manufacturers accelerate time to market and offering insights that help physicians achieve better patient outcomes.
FEops offers a unique pre-operative planning platform for structural heart interventions based on personalized predictive modelling. This scalable, automated and AI-enabled cloud-based platform contributes to better clinical outcome and improved procedure efficiency, and fosters market penetration and therapy adoption. FEops HEARTguide™ surpasses basic anatomical measurement, generating accurate predictions of how devices will interact with each unique patient. It is CE marked product with indication for use in TAVI (incl BAV patients) and LAAo.
Our cloud-based centralized platform houses the variable anatomy from hundreds of real patients and can model current or future devices across a diverse group of patients, moving beyond traditional bench and pre-clinical models, offering a future in-silico platform for the physician training and clinical trial environment.
Our end-to-end solution adds value to optimize and accelerate every step in the structural heart product life cycle, helping manufacturers accelerate time to market and bringing physicians insights that contribute to better patient outcomes.
The proprietary predictive simulation technology that drives the FEops HEARTguide™ suite gives device manufacturers tremendous power to accelerate the development of novel minimally invasive structural heart implants. Introduce virtual patients or digital twins into your workflows before making physical prototypes to gain time, cut costs, and test in clinically relevant contexts.
By improving patient selection and optimally preparing physicians for procedures through detailed predictive simulations, FEops HEARTguide™ can accelerate clinical trials and potentially contribute to better patient outcomes.
Make it intuitive for physicians to adopt and endorse novel structural heart devices with FEops HEARTguide™. Inspire confidence and accelerate the learning curve by providing physicians with predictive 3D images that demonstrate how the device will interact with the unique anatomy of each patient – without putting patients at risk.
In going beyond anatomical measurement, only FEops HEARTguide™ provides detailed preoperative insights into the interaction between the implant and the patient’s anatomy. This helps physicians to assist in the selection of device size and positioning.
GOAL 3 : GOOD HEALTH AND WELL-BEING
FEops ensures healthy lives and promote well-being for all at all ages. FEops HEARTguide cloud-based procedure planning environment uses predictive simulation to provide clinicians and medical device manufacturers with first-ever insights into the interaction between transcatheter structural heart devices and specific patient anatomy –preoperatively
Studies estimate the annual number of deaths due to medical errors in the hundreds of thousands, so there is great incentive to revise the way the medical profession gains knowledge and experience. Advances in 3D printing technology and virtual simulation are creating new opportunities to improve the quality of treatments and patient safety.
Have you been in a situation where a generic treatment did not work very well for you or someone you know? Have you ever had that nagging feeling that maybe the doctor (as good as he or she may be) should really be treating YOU rather than a generalized representation of you?
One in 160 children has an autism spectrum disorder according to the United Nations. Children with autism have learning and developmental disorders, and represent a number higher than all others disabilities put together. In the US alone, over 6.4% children have special needs in terms of cognitive, motor and sensory processing skills.
Inaccurate medications kill five times more people than road accidents do in developed countries. In France alone, this costs 10 billion euros to the public health system.
The Living Heart Project aims to advance the development of safe and effective cardiovascular products and treatments by uniting engineering, scientific, and biomedical expertise to translate cutting-edge science into improved patient care. Through simulation and the creation of validated models, the project aims to provide personalized, interventional patient care.
Two 3D experiences, ultra realistic on a scientific point of view, were created through collaborative projects with technologic and scientific partners: "Staying Alive" and "Born To Be Alive".
"Staying Alive" is a serious game that allows to learn appropriate behaviors for first aid techniques.
For patients with chronic illnesses, a primary goal is to create the best possible quality of life for living with a disease. During diagnosis or clinical trials , recording data from patients is often done over a too short a period of time for a proper clinical conclusion.
Skin cancer is the most common and fastest growing form of cancer in the world. The main risk factors for developing this type of cancer include exposure to UV radiation, age, sex, ethnicity, occupation, and family history of skin cancer. It is classified in 2 categories : melanoma, the deadliest form, and carcinoma, the most common type.
Do you think your project is the next big thing?
Join the team !